TP53 and cancer: Inhibiting cell cycle, triggering apoptosis, inhibiting tyrosine kinase, regulating p53 protein, and inhibiting antioxidant activity that interferes with several phases of cancer cell creation, development, differentiation, and metastasis (117, 139, 141–145).